Clinical trial
A Prospective, Multicentric, Open-labelled, Interventional Study to Assess Skin Beautification by Treating Fine Lines in the Neck, Perioral and Smiling Lines Areas With TEOSYAL RHA® 1
NCT05349799 is registered in ClinicalTrials.gov with Teoxane SA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicentric, Open-labelled, Interventional Study to Assess Skin Beautification by Treating Fine Lines in the Neck, Perioral and Smiling Lines Areas With TEOSYAL RHA® 1
- Lead sponsor
- Teoxane SA
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- October 5, 2021
- Completion date
- May 31, 2022
- Enrollment
- 67 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
fine lines of the face and neck, skin aging